Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...
11don MSN
Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback